Back to search

Caristo Diagnostics Limited

11429590

active
Private Limited Company
Companies House
Health Score
75 / 100

Some Concerns

25/30
Filing
10/30
Financial
40/40
Risk
  • No accounts filed in last 18 months (-5)
  • Current liabilities exceed current assets (-10)

Details

NEW BARCLAY HOUSE, OXFORD, OX2 0HP
Incorporated 22/06/2018

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

86220
Specialist medical practice activities

Officers

Mr Matthew Gerard Winston Frohn

director · Since 22/06/2018

VENTURE CAPITAL

BRITISH · UNITED KINGDOM · Age 59

Also on 19 other boards

Mr Charalambos Antoniades

director · Since 26/07/2018

CONSULTANT CARDIOLOGIST

CYPRIOT · UNITED KINGDOM · Age 51

Also on 1 other board

Doctor Liliane Chamas

director · Since 17/01/2025

INVESTOR

BRITISH,CANADIAN · UNITED KINGDOM · Age 39

Also on 2 other boards

Mr Timothy Shan Rea

director · Since 02/04/2025

INVESTOR

BRITISH · UNITED KINGDOM · Age 59

Also on 3 other boards

Maria Sainz

director · Since 24/06/2025

PRESIDENT AND CEO

SPANISH · UNITED STATES · Age 60

Also on 1 other board

Mr William James Middleton

director · Since 19/12/2025

BRITISH,AUSTRALIAN · UNITED KINGDOM · Age 43

Also on 2 other boards

Michel Joseph Lussier

director · Since 19/12/2025

BELGIAN · BELGIUM · Age 69

Mr Stephen Matthew Deitsch

director · Since 01/04/2026

USA · USA · Age 54

Persons with Significant Control

Oxford Science Enterprises Holdings Limited

25–50% shares
25–50% votes

46, Woodstock Road, Oxford, OX2 6HT

Reg: 13564426 · Companies House · Corporate

Notified 31/03/2025

Former PSCs

Athanasia Karydi

Ceased 20/07/2018

Mr Charalambos Antoniades

Ceased 26/07/2018

Oxford Science Enterprises Plc

Ceased 31/03/2025

CompanyRankvs 680+ SIC 86220 peers
83

Financial strength99th percentile among SIC peers · 25/25
Employees100th percentile among SIC peers · 15/15
LiquidityCurrent ratio 3.78× · 20/20
Longevity8 years trading (max 15) · 8/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength25/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees15/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity8/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2022

Net Worth

£2.6M

Balance sheet strength

Cash

£2.2M

Cash in the bank

Net Current Assets

£2.6M

Working capital

Current Assets

£3.5M

Current Liabilities

£928k

Fixed Assets

£62k

Debtors

£1.3M

Profit After Tax

-£4.0M

33avg. employees+13

Balance Sheet

Assets less current liabilities£2.6M
Prepared with Caseware UK (AP4) 2022.0.179

EstimatesDerived

YearCurrent RatioImplied Profit
20223.78-£3.9M
202112.79+£6.2M
20202.02-£799k
20198.04

Derived from filed accounts. Not audited figures.